Brigatinib

ATC L01ED04 · 10 markets · 42 records

Brigatinib 10 markets · 42 records Forms

AU 12 records · 4 strengths

  • 90 mgtabletAlunbrigALUNBRIG brigatinib 180 mg film-coated tablet blister pack、ALUNBRIG brigatinib 30 mg film-coated tablet bottle、ALUNBRIG brigatinib 90 mg and 180 mg film-coated tablets blister pack also in GB·CA·SG +4 unknown
  • 180 mgtabletAlunbrigALUNBRIG brigatinib 180 mg film-coated tablet blister pack、ALUNBRIG brigatinib 30 mg film-coated tablet bottle、ALUNBRIG brigatinib 90 mg and 180 mg film-coated tablets blister pack also in GB·CA·SG +4 unknown
  • 30 mgtabletAlunbrigALUNBRIG brigatinib 180 mg film-coated tablet blister pack、ALUNBRIG brigatinib 30 mg film-coated tablet bottle also in GB·CA·SG +4 unknown

Records without a stated strength · 1 Alunbrig

GB 4 records · 3 strengths

CA 4 records · 3 strengths

SG 4 records · 3 strengths

CN 4 records · 3 strengths

ES 4 records · 3 strengths

US 3 records · 3 strengths

TW 3 records · 3 strengths

  • 90 mgtabletAlunbrig癌能畢 膜衣錠90毫克 also in AU·GB·CA +4
  • 180 mgtabletAlunbrig癌能畢 膜衣錠180毫克 also in AU·GB·CA +4
  • 30 mgtabletAlunbrig癌能畢 膜衣錠30毫克 also in AU·GB·CA +4

HK 3 records · 1 strengths

    Records without a stated strength · 1 Alunbrig

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      Records without a stated strength · 1 Alunbrig

      Side-by-side table

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.